The core activity of Saviela AG is investment and trade in the pharmaceutical industry, particularly in veterinary medicine. Specifically, this includes: equity investments in biotechnology companies, research and development in the field of pharmaceuticals, trade in active pharmaceutical ingredients (API) and other pharmaceutical products, especially for the veterinary medicine sector, and management of patents and trademark rights. The company has a focus on European and African markets and has extensive experience and a broad network in veterinary medicine.